EUVIMEDEUVIMED entdecken
Crossref

Changes in dynamic and static functional connectivity in amygdala subregions in major depressive disorder treated with esketamine in and sertraline: A pilot study

Xiang Liu, Lifeng Li, Haijun Li, Yingke Deng, Yumeng Liu, Dechang Peng, Guojiang Wu, Xueming Zhou

Journal of Affective Disorders · 2026-01 · 392 · 120156

DOI: 10.1016/j.jad.2025.120156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2026-01. Verfasst von Xiang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory for Precision Pathology and Intelligent Diagnosis, Department of Radiology, The First Affiliated Hospital, Jiangxi …. Hauptthemen laut MEDLINE: Major Depressive Disorder, Sertraline, Ketamine, Amygdala. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Jiangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Dysfunction in amygdala networks has been implicated in major depressive disorder (MDD). Pharmacological treatments, such as esketamine and sertraline, are believed to exert their antidepressant effects by modulating amygdalar activity. This study aimed to investigate the relationship between changes in dynamic functional connectivity (dFC) within amygdala subregions and treatment outcomes, with a focus on identifying potential neuroimaging markers. METHODS: Twenty-eight patients with MDD received six intravenous infusions of esketamine (0.25 mg/kg) combined with 2 weeks of sertraline treatment. Mood and cognitive recovery were assessed using the HAMA, HAMD, BSI, and MoCA. Seed-based dFC analysis of resting-state MRI focused on the dorsal amygdala (DA), medial amygdala (MA), and ventrolateral amygdala (VA). RESULTS: All patients demonstrated positive responses to treatment, with significant reductions in HAMA and HAMD scores, as well as improvements in MoCA scores and a decrease in suicidal ideation. Following treatment, static functional connectivity (sFC) was reduced between the right DA and paracentral lobule, the left VA and multiple regions (including the lentiform nucleus, thalamus, medial prefrontal cortex, inferior parietal lobule, precentral gyrus, and superior parietal lobule), and the right VA and middle frontal gyrus. Conversely, dFC was significantly increased between the right DA and cuneus/superior parietal lobule, and between the left VA and superior parietal lobule. A decrease in dFC was also observed between the left MA and superior temporal gyrus. Correlation analysis showed that dFC between the left MA and superior temporal gyrus was positively correlated with HAMA score. LIMITATION: The combined use of esketamine and sertraline limits the ability to differentiate their individual effects. A significant proportion of the patients were adolescents, with only a few adults, which may influence the age-related response to treatment. The study utilized the lowest effective dose of esketamine, thereby leaving the dose-response relationships unexamined. The small sample size further restricts the statistical power of the findings, highlighting the need for larger studies to validate these results. CONCLUSION: Altered resting-state and dFC in amygdala subregions may play a role in the mechanisms by which the combination of esketamine and sertraline alleviates depressive symptoms, primarily involving the sensorimotor and default mode networks. Together, the sFC and dFC analyses provide an integrated perspective on depression-related connectivity changes and offer potential targets for treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderSertralineKetamineAmygdalaAntidepressive AgentsHumansPilot ProjectsMaleFemaleAdultMagnetic Resonance ImagingMiddle AgedTreatment OutcomeDrug Therapy, CombinationNeural Pathways

Stichwörter der Autor:innen

Dynamic functional connectionEsketamineMajor depressive disorderSertraline

Substanzen

SertralineKetamineAntidepressive AgentsEsketamine

Autor:innen und Institutionen

  • Jiangxi Provincial Key Laboratory for Precision Pathology and Intelligent Diagnosis, Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, China.
  • Jiangxi Provincial Key Laboratory for Precision Pathology and Intelligent Diagnosis, Department of Radiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, China. Electronic address: pengd…
  • Department of Psychosomatic Medicine, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Jiangxi, China. Electronic address: wgjaizyp@163.com.
  • Department of Traditional Chinese Medicine, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Jiangxi, China. Electronic address: 13207007666@163.com.

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Jiangxi Province

Zitieren

APA

Liu, X., Li, L., Li, H., Deng, Y., Liu, Y., Peng, D., Wu, G., & Zhou, X. (2026). Changes in dynamic and static functional connectivity in amygdala subregions in major depressive disorder treated with esketamine in and sertraline: A pilot study. Journal of Affective Disorders, 392, 120156. https://doi.org/10.1016/j.jad.2025.120156

Vancouver

Liu X, Li L, Li H, Deng Y, Liu Y, Peng D, et al. Changes in dynamic and static functional connectivity in amygdala subregions in major depressive disorder treated with esketamine in and sertraline: A pilot study. Journal of Affective Disorders. 2026;392:120156. doi:10.1016/j.jad.2025.120156

BibTeX
@article{Liu2026,
  author = {Liu, Xiang and Li, Lifeng and Li, Haijun and Deng, Yingke and Liu, Yumeng and Peng, Dechang and Wu, Guojiang and Zhou, Xueming},
  title = {Changes in dynamic and static functional connectivity in amygdala subregions in major depressive disorder treated with esketamine in and sertraline: A pilot study},
  journal = {Journal of Affective Disorders},
  year = {2026},
  volume = {392},
  pages = {120156},
  doi = {10.1016/j.jad.2025.120156}
}
Kostenlos starten →